In Silico Identification of New Anti-SARS-CoV-2 Main Protease (Mpro) Molecules with Pharmacokinetic Properties from Natural Sources Using Molecular Dynamics (MD) Simulations and Hierarchical Virtual Screening
Infectious agents such as SARS-CoV, MERS-CoV, and SARS-CoV-2 have emerged in recent years causing epidemics with high mortality rates. The quick development of novel therapeutic compounds is required in the fight against such pathogenic agents. Unfortunately, the traditional drug development methods...
Saved in:
Main Authors: | Harrison Onyango, Patrick Odhiambo, David Angwenyi, Patrick Okoth |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Tropical Medicine |
Online Access: | http://dx.doi.org/10.1155/2022/3697498 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Isolation and In Silico Anti-COVID-19 Main Protease (Mpro) Activities of Flavonoids and a Sesquiterpene Lactone from Artemisia sublessingiana
by: Roza I. Jalmakhanbetova, et al.
Published: (2021-01-01) -
In silico binding role of flavonoids as SARS-CoV-2 main protease (Mpro) inhibitors: A dataset of molecular docking simulation-based high-throughput virtual screening (HTVS)Mendeley Data
by: Mariyam Eema, et al.
Published: (2025-04-01) -
Promising inhibitors against main protease of SARS CoV-2 from medicinal plants: In silico identification
by: EBENEZER OLUWAKEMI, et al.
Published: (2022-06-01) -
Multistaged In Silico Discovery of the Best SARS-CoV-2 Main Protease Inhibitors amongst 3009 Clinical and FDA-Approved Compounds
by: Ibrahim H. Eissa, et al.
Published: (2024-01-01) -
Inhibition of the SARS-CoV-2 Main Protease by Isoquercitrin γ-Cyclodextrin Inclusion Complex Formulations: A Biochemical and In Silico Study
by: Martin Wurtele, et al.
Published: (2023-01-01)